ePrints

Targeting tropomyosin receptor kinase in cutaneous CYLD defective tumors (TRAC): A randomised placebo-controlled early phase trial with pegcantratinib

Lookup NU author(s): Dr Marina Danilenko, Elaine Stamp, Dr Deborah Stocken, Monique Zangarini, Amy Cranston, Robert Stones, Naomi Sinclair, Kirsty Hodgson, Dr Susan BowettORCiD, Professor Ruth Plummer, Professor Gareth Veal, Dr James Langtry, Professor Sir John BurnORCiD, Professor Neil RajanORCiD

Downloads

• Published version [.pdf]

Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).

Publication metadata

Author(s): Danilenko M, Stamp E, Stocken DD, Husain A, Zangarini M, Cranston A, Stones R, Sinclair N, Hodgson K, Bowett SA, Roblin D, Traversa S, Plummer R, Veal G, Langtry JAA, Ashworth A, Burn J, Rajan N

Publication type: Article

Publication status: Published

Journal: JAMA Dermatology

Year: 2018

Volume: 154

Issue: 8

Pages: 913-921

Print publication date: 01/08/2018

Online publication date: 27/06/2018

Acceptance date: 18/04/2018

Date deposited: 03/07/2018

ISSN (print): 2168-6068

ISSN (electronic): 2168-6084

Publisher: American Medical Association

URL: https://doi.org/10.1001/jamadermatol.2018.1610

DOI: 10.1001/jamadermatol.2018.1610

Altmetrics

Funding

Share